+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

Insulin Pen Needles - Global Strategic Business Report - Product Thumbnail Image

Insulin Pen Needles - Global Strategic Business Report

  • Report
  • March 2025
  • 193 Pages
  • Global
From
Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Rapid Acting Insulin Market Report by Product, Indication, Distribution Channel, and Region 2024-2032

  • Report
  • September 2024
  • 135 Pages
  • Global
From
Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • August 2024
  • 150 Pages
  • Global
From
JARDIANCE Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

JARDIANCE Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
human insulin market - Forecasts from 2025 to 2030 - Product Thumbnail Image

human insulin market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Diabetic Nephropathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Nephropathy - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 80 Pages
  • Global
From
Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Diabetes Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 150 Pages
  • Global
From
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 184 Pages
  • Global
From
Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Semaglutide - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Trulicity - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Thumbnail Image

Trulicity - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region - Product Thumbnail Image

Insulin Biosimilar Market by Type of Insulin, by Mode of Administration, by Therapeutic Application, by Distribution Channel, and by Region

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Non-insulin Diabetes Therapeutics Market 2024-2028 - Product Thumbnail Image

Non-insulin Diabetes Therapeutics Market 2024-2028

  • Report
  • August 2024
  • 178 Pages
  • Global
From
Insulin Syringes Market 2024-2028 - Product Thumbnail Image

Insulin Syringes Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Thumbnail Image

Metformin HCL Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • January 2025
  • 182 Pages
  • Global
From
Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Type 1 Diabetes: Epidemiology Forecast to 2033 - Product Thumbnail Image

Type 1 Diabetes: Epidemiology Forecast to 2033

  • Report
  • November 2024
  • 69 Pages
  • Global
From
Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Regional Outlook and Forecast, 2024-2031 - Product Thumbnail Image

Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Regional Outlook and Forecast, 2024-2031

  • Report
  • August 2024
  • 268 Pages
  • Global
From
Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user - Product Thumbnail Image

Human Insulin Market Size and Forecasts 2020-2031: Global and Regional Share, Trends, and Growth Opportunity Analysis by Product Type, Application, and End-user

  • Report
  • September 2024
  • 117 Pages
  • Global
From
Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Biologics, Wound Care Dressings), Type (Neuro-Ischemic, Neuropathic), End-use, Country, and Segment Forecasts, 2025-2030 - Product Thumbnail Image

Europe Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report by Treatment (Biologics, Wound Care Dressings), Type (Neuro-Ischemic, Neuropathic), End-use, Country, and Segment Forecasts, 2025-2030

  • Report
  • October 2024
  • 124 Pages
  • Europe
From
North America Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031 - Product Thumbnail Image

North America Human Insulin Market Size, Share & Trends Analysis Report by Indication, Product Type (Pens, Syringes, and Others), Type of Insulin, Distribution Channel, Country and Growth Forecast, 2024-2031

  • Report
  • August 2024
  • 110 Pages
  • North America
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more